I-Newgreen Factory Supply Rimonabant High Quality 99% Rimonabant Powder
Incazelo Yomkhiqizo
I-Rimonabant iyisidakamizwa esisetshenziswa ngokuyinhloko ukwelapha ukukhuluphala kanye nezifo ezihlobene ne-metabolic. Okulandelayo yisingeniso se-Rimonabant:
1. Isigaba sezidakamizwa
I-Rimonabant iyisitha esikhethayo se-cannabinoid uhlobo 1 (CB1) futhi ingeyesigaba esisha sezidakamizwa ezilwa nokukhuluphala.
2. Injongo Eyinhloko
Ukuncipha Kwesisindo: I-Rimonabant ithuthukiswa ukusiza iziguli ezikhuluphele ukuba zilahlekelwe isisindo, ikakhulukazi lezo ezine-metabolic syndrome.
Ithuthukisa Impilo Ye-Metabolic: Ngaphandle kokulahlekelwa isisindo, i-Rimonabant ikholelwa ukuthi ithuthukisa izinkinga ze-metabolic ezihlobene nokukhuluphala, njengoshukela wegazi ophezulu, i-cholesterol ephezulu kanye nomfutho wegazi ophezulu.
Ekuphetheni, i-Rimonabant iyisidakamizwa sokukhuluphala kanye nesifo se-metabolic esinendlela ethile yokusebenza kanye nempumelelo engenzeka, kodwa ukusetshenziswa kwayo kunqunyelwe ngokuqinile ngenxa yengozi yemiphumela emibi. Kufanele isetshenziswe ngaphansi kokuqondisa kukadokotela kanye nokuqapha okufanele.
I-COA
| Izinto | Imininingwane | Imiphumela |
| Ukubukeka | Valiwe-impushana emhlophe noma emhlophe | Impushana Emhlophe |
| I-HPLC Identification | Ngokuhambisana nereferensi isikhathi sokugcina isiqongo esiyinhloko | Kuyavumelana |
| Ukuzungezisa okuqondile | +20.0.+22.0. | +21. |
| Izinsimbi ezinzima | ≤ 10ppm | <10ppm |
| PH | 7.58.5 | 8.0 |
| Ukulahlekelwa ekomisweni | ≤ 1.0% | 0.25% |
| Ukuhola | ≤3ppm | Kuyavumelana |
| I-Arsenic | ≤1ppm | Kuyavumelana |
| I-Cadmium | ≤1ppm | Kuyavumelana |
| I-Mercury | ≤0. 1 ppm | Kuyavumelana |
| Iphoyinti lokuncibilika | 250.0℃~265.0℃ | 254.7~255.8℃ |
| Izinsalela ekushiseni | ≤0. 1% | 0.03% |
| IHydrazine | ≤2ppm | Kuyavumelana |
| Ukuminyana ngobuningi | / | 0.21g/ml |
| Ukuminyana okuthenjiwe | / | 0.45g/ml |
| I-Assay (Rimonabant) | 99.0%~ 101.0% | 99.55% |
| Izibalo eziphelele ze-aerobes | ≤1000CFU/g | <2CFU/g |
| Isikhunta & Imvubelo | ≤100CFU/g | <2CFU/g |
| E.coli | Okubi | Okubi |
| I-Salmonella | Okubi | Okubi |
| Isitoreji | Gcina endaweni epholile neyomile, vikela ukukhanya okuqinile. | |
| Isiphetho | Ufanelekile | |
Umsebenzi
I-Rimonabant iyisidakamizwa esisetshenziswa ngokuyinhloko ekulawuleni isisindo kanye nokwelashwa kwe-metabolic syndrome ehambisana nokukhuluphala. Okulandelayo yisingeniso semisebenzi ye-Rimonabant:
1. Ukunciphisa Isifiso Sokudla
I-Rimonabant ingumphikisi we-cannabinoid 1 (CB1) okhethiwe osiza ukuphatha isisindo ngokuvimbela umsebenzi wama-cannabinoid receptors, ukunciphisa isifiso sokudla.
2. Ukuncipha kwesisindo
I-Rimonabant isetshenziselwa ukusiza iziguli ezikhuluphele ukuba zilahlekelwe isisindo, ikakhulukazi lezo ezine-metabolic syndrome (njengomfutho wegazi ophezulu, ushukela wegazi ophezulu, kanye ne-cholesterol ephezulu).
3. Izinkomba ezithuthukisiwe ze-metabolic
Ukusetshenziswa kwe-Rimonabant kungathuthukisa izimpawu ze-metabolic ezihlobene nokukhuluphala, njengamafutha omzimba ancishisiwe, ukuzwela kwe-insulin okuthuthukisiwe, kanye namazinga kashukela egazi aphansi.
4. Umthelela wezempilo yengqondo
Olunye ucwaningo lubonisa ukuthi i-rimonabant ingase ibe nemiphumela emihle ekuthuthukiseni impilo yengqondo, ikakhulukazi ekwehliseni izimpawu zokucindezeleka ezihlobene nokukhuluphala.
5. Imiphumela Emibi
Nakuba i-rimonabant ibonise amandla okulawula isisindo, ukusetshenziswa kwayo kubuye kuhlotshaniswe neminye imiphumela emibi, njengokukhathazeka, ukucindezeleka, isicanucanu kanye nekhanda. Ngenxa yalokho, ukusetshenziswa kwe-rimonabant kukhawulelwe noma kuhoxisiwe emazweni amaningi.
Ngamafuphi, umsebenzi oyinhloko we-Rimonabant ukusiza iziguli ezikhuluphele ukuba zilahlekelwe isisindo ngokucindezela ukudla nokuthuthukisa izinkomba ze-metabolic. Nokho, ngenxa yemiphumela yayo emibi, kufanele isetshenziswe ngokuqapha futhi ngaphansi kokuqondiswa udokotela.
Isicelo
Ukusetshenziswa kwe-Rimonabant kugxile kakhulu kulezi zici ezilandelayo:
1. Ukwelashwa kokukhuluphala:
I-Rimonabant yasungulwa ekuqaleni ukuze iphathe ukukhuluphala, ikakhulukazi ezigulini ezikhuluphele futhi ezine-metabolic syndrome (njengoshukela wegazi ophezulu, i-lipids ephezulu yegazi kanye nomfutho wegazi ophezulu). Isiza iziguli ukuthi zilahlekelwe isisindo ngokunciphisa isifiso sokudla kanye nokukhuthaza i-fat metabolism.
2. I-Metabolic syndrome:
I-Rimonabant ifundelwa ukuthuthukisa izimpawu ezihambisana nesifo se-metabolic, esiza ukunciphisa isisindo somzimba, ukuthuthukisa ukuzwela kwe-insulin nokunciphisa amazinga e-lipid egazi.
3. Ukulawula isifo sikashukela:
Kwezinye izifundo, i-ribonabant ibonise izinzuzo ezingase zibe khona kubantu abanesifo sikashukela sohlobo 2, okungenzeka ukusiza ukulawula amazinga kashukela egazini ngokwenza ngcono isimo se-metabolic kanye nokuphathwa kwesisindo.
4. Impilo Yenhliziyo:
Ngenxa yemiphumela yayo empilweni ye-metabolic, i-Rimonabant iphinde ifundelwe ukuthuthukisa impilo yenhliziyo kanye nokunciphisa ingozi yesifo senhliziyo.
Amanothi
Nakuba i-rimonabant ibonise amandla ekwelapheni ukukhuluphala kanye nesifo se-metabolic, ukugunyazwa kwayo kwemakethe kuhoxisiwe emazweni amaningi ngenxa yemiphumela yayo engemihle ehlobene nempilo yengqondo, njengokucindezeleka nokukhathazeka. Ngakho-ke, i-rimonabant kufanele isetshenziswe ngokuqapha futhi ilandele isiqondiso sikadokotela.
Kafushane, ukusetshenziswa okuyinhloko kwe-rimonabant kungokokwelapha ukukhuluphala kanye nesifo se-metabolic, kodwa ukusetshenziswa kwayo kunqunyelwe ngenxa yezinkinga zokuphepha.
Iphakheji Nokulethwa
